Clinical Trial Update: Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a novel controlled hypo-perfusion technique during partial nephrectomy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Partial Nephrectomy, Renal Cell Carcinoma | Phase 2 | Status: TERMINATED